MedPath

Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta

Phase 2
Completed
Conditions
Osteogenesis Imperfecta
Registration Number
NCT00131118
Lead Sponsor
Novartis Pharmaceuticals
Brief Summary

This is an extension study to examine the long-term safety and efficacy of zoledronic acid in patients who have completed the core CZOL446H2202 study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
127
Inclusion Criteria
  • Have completed the core CZOL446H2202 study
  • Males or females between 1-17 years of age
Exclusion Criteria
  • Deformity or abnormality which would prevent spine bone density from being done
  • Any surgical bone-lengthening procedure
  • Any kidney diseases or abnormalities
  • Low calcium or vitamin D levels in the blood

Other protocol-defined inclusion/exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Long-term safety of two different zoledronic acid doses over an additional 12 months in patients who have completed one year treatment in CZOL446H2202
Secondary Outcome Measures
NameTimeMethod
Measure percentage change of lumbar spine bone mineral density at month 18 and 24 compared to baseline in the core study.

Trial Locations

Locations (9)

UCLA Medical Center-Dept of Pediatric Nephrology

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Alfred Dupont Hospital for Children

πŸ‡ΊπŸ‡Έ

Wilmington, Delaware, United States

Intermountains Orthopedics

πŸ‡ΊπŸ‡Έ

Boise, Idaho, United States

Children's Hospital

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

For information regarding facilities, please contact the Central Contact

πŸ‡ΊπŸ‡Έ

Multiple Locations, New Jersey, United States

Children's Hospital Medical Center

πŸ‡ΊπŸ‡Έ

Cincinnati, Ohio, United States

Oregon Health Sciences University

πŸ‡ΊπŸ‡Έ

Portland, Oregon, United States

Vanderbilt University Medical Center

πŸ‡ΊπŸ‡Έ

Nashville, Tennessee, United States

Texas Children's Hospital

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

UCLA Medical Center-Dept of Pediatric Nephrology
πŸ‡ΊπŸ‡ΈLos Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.